| 000 | 01544 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514034132.0 | ||
| 264 | 0 | _c20020723 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1006/gyno.2002.6665 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHofstra, L S | |
| 245 | 0 | 0 |
_aKinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cJun 2002 |
||
| 300 |
_a517-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 700 | 1 | _aBos, A M E | |
| 700 | 1 | _ade Vries, E G E | |
| 700 | 1 | _avan der Zee, A G J | |
| 700 | 1 | _aWillemsen, A T M | |
| 700 | 1 | _aRosing, H | |
| 700 | 1 | _aBeijnen, J H | |
| 700 | 1 | _aMulder, N H | |
| 700 | 1 | _aAalders, J G | |
| 700 | 1 | _aWillemse, P H B | |
| 773 | 0 |
_tGynecologic oncology _gvol. 85 _gno. 3 _gp. 517-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/gyno.2002.6665 _zAvailable from publisher's website |
| 999 |
_c11948104 _d11948104 |
||